A simple algorithm locates β-strands in the amyloid fibril core of α-synuclein, Aβ, and tau using the amino acid sequence alone

Protein Science

Volumn 16, Issue 5, 2007, Pages 906-918

  Zibaee, Shahin ^a,b   Makin, O Sumner ^a,c   Goedert, Michel ^b   Serpell, Louise C ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^c UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

synuclein; strand propensity; Algorithm; Alzheimer's disease; Amyloid fibril; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; BETA SYNUCLEIN; TAU PROTEIN;

ALGORITHM; ALPHA HELIX; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; BETA SHEET; HYDROPHOBICITY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY;

ALGORITHMS; ALPHA-SYNUCLEIN; AMYLOID; AMYLOID BETA-PROTEIN; BETA-SYNUCLEIN; PROTEIN STRUCTURE, SECONDARY; TAU PROTEINS;

EID: 34247591802     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1110/ps.062624507     Document Type: Article

References (113)

1. Abraha, A., Ghoshal, N., Gamblin, T.C., Cryns, V., Berry, R.W., Kuret, J., and Binder, L.I. 2000. C-terminal inhibition of τ assembly in vitro and in Alzheimer's disease. J. Cell Sci. 113: 3737-3745.
2. Alonzo, N.C., Hyman, B.T., Rebeck, G.W., and Greenberg, S.M. 1998. Progression of cerebral amyloid angiopathy: Accumulation of amyloid-β40 in affected vessels. J. Neuropathol. Exp. Neurol. 57: 353-359.
3. Alzheimer, A. 1907. Über eine eigenartige Erkrankung der Hirnrinde. Allg. Z. Psychiatr. 64: 146-148.
4. Baba, M., Nakajo, S., Tu, P.H., Tomita, T., Nakaya, K., Lee, V.M., Trojanowski, J.Q., and Iwatsubo, T. 1998. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152: 879-884.
5. Balbach, J.J., Petkova, A.T., Oyler, N.A., Antzutkin, O.N., Gordon, D.J., Meredith, S.C., and Tycko, R. 2002. Supramolecular structure in full-length Alzheimer's β-amyloid fibrils: Evidence for a parallel β-sheet organization from solid-state nuclear magnetic resonance. Biophys. J. 83: 1205-1216.
6. Berriman, J., Serpell, L.C., Oberg, K.A., Fink, A.L., Goedert, M., and Crowther, R.A. 2003. τ filaments from human brain and from in vitro assembly of recombinant protein show cross-β structure. Proc. Natl. Acad. Sci. 100: 9034-9038.
7. Bisaglia, M., Tessari, I., Pinato, L., Bellanda, M., Giraudo, S., Fasano, M., Bergantino, E., Bubacco, L., and Mammi, S. 2005. A topological model of the interaction between α-synuclein and sodium dodecyl sulfate micelles. Biochemistry 44: 329-339.
8. Bodles, A.M., Guthrie, D.J., Harriott, P., Campbell, P., and Irvine, G.B. 2000. Toxicity of non-Aβ component of Alzheimer's disease amyloid, and N-terminal fragments thereof, correlates to formation of β-sheet structure and fibrils. Eur. J. Biochem. 267: 2186-2194.
9. Bodles, A.M., Guthrie, D.J., Greer, B., and Irvine, G.B. 2001. Identification of the region of non-Aβ component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity. J. Neurochem. 78: 384-395.
10. Booth, D.R., Sunde, M., Bellotti, V., Robinson, C.V., Hutchinson, W.L., Fraser, P.E., Hawkins, P.N., Dobson, C.M., Radford, S.E., Blake, C.C., et al. 1997. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 385: 787-793.
11. Brion, J.P., Passareiro, H., Nunez, J., and Flament-Durand, J. 1985. Mise en évidence immunologique de la protéine τ au niveau des lésions de dégénérescence neurofibrillaire de la maladie d'Alzheimer. Arch. Biol. (Bruxelles) 95: 229-235.
12. Bronner, I.F., ter Meulen, B.C., Azmani, A., Severijnen, L.A., Willemsen, R., Kamphorst, W., Ravid, R., Heutink, P., and van Swieten, J.C. 2005. Hereditary Pick's disease with the G272V τ mutation shows predominant three-repeat τ pathology. Brain 128: 2645-2653.
13. Buée-Scherrer, V., Hof, P.R., Buée, L., Leveugle, B., Vermersch, P., Perl, D.P., Olanow, C.W., and Delacourte, A. 1996. Hyperphosphorylated τ proteins differentiate corticobasal degeneration and Pick's disease. Acta Neuropathol. (Berl.) 91: 351-359.
14. Bussell Jr., R. and Eliezer, D. 2003. A structural and functional role for 11-mer repeats in α-synuclein and other exchangeable lipid binding proteins. J. Mol. Biol. 329: 763-778.
15. Bussell Jr., R., Ramlall, T.F., and Eliezer, D. 2005. Helix periodicity, topology, and dynamics of membrane-associated α-synuclein. Protein Sci. 14: 862-872.
16. Chandra, S., Chen, X., Rizo, J., Jahn, R., and Sudhof, T.C. 2003. A broken α-helix in folded α-synuclein. J. Biol. Chem. 278: 15313-15318.
17. Chiti, F., Taddei, N., Baroni, F., Capanni, C., Stefani, M., Ramponi, G., and Dobson, C.M. 2002. Kinetic partitioning of protein folding and aggregation. Nat. Struct. Biol. 9: 137-143.
18. Chiti, F., Stefani, M., Taddei, N., Ramponi, G., and Dobson, C.M. 2003. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 424: 805-808.
19. Chou, P.Y. and Fasman, G.D. 1974a. Conformational parameters for amino acids in helical, β-sheet, and random coil regions calculated from proteins. Biochemistry 13: 211-222.
20. Chou, P.Y. and Fasman, G.D. 1974b. Prediction of protein conformation. Biochemistry 13: 222-245.
21. Chou, P.Y. and Fasman, G.D. 1978. Prediction of the secondary structure of proteins from their amino acid sequence. Adv. Enzymol. Relat. Areas Mol. Biol. 47: 45-148.
22. Clark, L.N., Poorkaj, P., Wszolek, Z., Geschwind, D.H., Nasreddine, Z.S., Miller, B., Li, D., Payami, H., Awert, F., Markopoulou, K., et al. 1998. Pathogenic implications of mutations in the τ gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc. Natl. Acad. Sci. 95: 13103-13107.
23. Colon, W. and Kelly, J.W. 1991. Transthyretin acid induced denaturation is required for amyloid fibril formation in vitro. In Applications of enzyme biotechnology (eds. J.W. Kelly and T.O. Baldwin), pp. 99-108. Springer, New York.
24. Connell, J.W., Rodriguez-Martin, T., Gibb, G.M., Kahn, N.M., Grierson, A.J., Hanger, D.P., Revesz, T., Lantos, P.L., Anderton, B.H., and Gallo, J.M. 2005. Quantitative analysis of t isoform transcripts in sporadic τ opathies. Brain Res. Mol. Brain Res. 137: 104-109.
25. Crowther, T., Goedert, M., and Wischik, C.M. 1989. The repeat region of microtubule-associated protein τ forms part of the core of the paired helical filament of Alzheimer's disease. Ann. Med. 21: 127-132.
26. Davidson, W.S., Jonas, A., Clayton, D.F., and George, J.M. 1998. Stabilization of α-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273: 9443-9449.
27. Davis-Salinas, J., Saporito-Irwin, S.M., Cotman, C.W., and Van Nostrand, W.E. 1995. Amyloid β-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J. Neurochem. 65: 931-934.
28. Del Mar, C., Greenbaum, E.A., Mayne, L., Englander, S.W., and Woods Jr., V.L. 2005. Structure and properties of α-synuclein and other amyloids determined at the amino acid level. Proc. Natl. Acad. Sci. 102: 15477-15482.
29. Der-Sarkissian, A., Jao, C.C., Chen, J., and Langen, R. 2003. Structural organization of α-synuclein fibrils studied by site-directed spin labeling. J. Biol. Chem. 278: 37530-37535.
30. Du, H.N., Tang, L., Luo, X.Y., Li, H.T., Hu, J., Zhou, J.W., and Hu, H.Y. 2003. A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human α-synuclein. Biochemistry 42: 8870-8878.
31. Eanes, E.D. and Glenner, G.G. 1968. X-ray diffraction studies on amyloid filaments. J. Histochem. Cytochem. 16: 673-677.
32. Eisenberg, D., Weiss, R.M., and Terwilliger, T.C. 1982. The helical hydrophobic moment: A measure of the amphiphilicity of a helix. Nature 299: 371-374.
33. Eisenberg, D., Schwarz, E., Komaromy, M., and Wall, R. 1984. Analysis of membrane and surface protein sequences with the hydrophobic moment plot. J. Mol. Biol. 179: 125-142.
34. El-Agnaf, O.M., Bodles, A.M., Guthrie, D.J., Harriott, P., and Irvine, G.B. 1998a. The N-terminal region of non-Aβ component of Alzheimer's disease amyloid is responsible for its tendency to assume β-sheet and aggregate to form fibrils. Eur. J. Biochem. 258: 157-163.
35. El-Agnaf, O.M., Jakes, R., Curran, M.D., Middleton, D., Ingenito, R., Bianchi, E., Pessi, A., Neill, D., and Wallace, A. 1998b. Aggregates from mutant and wild-type α-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β-sheet and amyloid-like filaments. FEBS Lett. 440: 71-75.
36. Eliezer, D., Kutluay, E., Bussell Jr., R., and Browne, G. 2001. Conformational properties of α-synuclein in its free and lipid-associated states. J. Mol. Biol. 307: 1061-1073.
37. Fernandez-Escamilla, A.M., Rousseau, F., Schymkowitz, J., and Serrano, L. 2004. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol. 22: 1302-1306.
38. Fryer, J.D., Taylor, J.W., DeMattos, R.B., Bales, K.R., Paul, S.M., Parsadanian, M., and Holtzman, D.M. 2003. Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice. J. Neurosci. 23: 7889-7896.
39. Gazit, E. 2002. A possible role for pi-stacking in the self-assembly of amyloid fibrils. FASEB J. 16: 77-83.
40. Giasson, B.I., Murray, I.V.J., Trojanowski, J.Q., and Lee, V.M.-Y. 2001. A hydrophobic stretch of 12 amino acid residues in the middle of α-synuclein is essential for filament assembly. J. Biol. Chem. 276: 2380-2386.
41. Glenner, G.G. and Wong, C.W. 1984. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120: 885-890.
42. Glenner, G.G., Eanes, E.D., Bladen, H.A., Linke, R.P., and Termine, J.D. 1974. Beta-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils. J. Histochem. Cytochem. 22: 1141-1158.
43. Goedert, M. 2001. Alpha-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci. 2: 492-501.
44. Goedert, M. and Spillantini, M.G. 2006. A century of Alzheimer's disease. Science 314: 777-781.
45. Goedert, M., Wischik, C.M., Crowther, R.A., Walker, J.E., and Klug, A. 1988. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: Identification as the microtubule-associated protein τ. Proc. Natl. Acad. Sci. 85: 4051-4055.
46. Goedert, M., Spillantini, M.G., Crowther, R.A., Chen, S.G., Parchi, P., Tabaton, M., Lanska, D.J., Markesbery, W.R., Wilhelmsen, K.C., Dickson, D.W., et al. 1999. τ gene mutation in familial progressive subcortical gliosis. Nat. Med. 5: 454-457.
47. Gregory, G.C. and Halliday, G.M. 2005. What is the dominant Aβ species in human brain tissue? A review. Neurotox. Res. 7: 29-41.
48. Grover, A., DeTure, M., Yen, S.H., and Hutton, M. 2002. Effects on splicing and protein function of three mutations in codon N296 of τ in vitro. Neurosci. Lett. 323: 33-36.
49. Guijarro, J.I., Sunde, M., Jones, J.A., Campbell, I.D., and Dobson, C.M. 1998. Amyloid fibril formation by an SH3 domain. Proc. Natl. Acad. Sci. 95: 4224-4228.
50. Han, H., Weinreb, P.H., and Lansbury Jr., P.T. 1995. The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by β-amyloid: Is NAC a common trigger or target in neurodegenerative disease? Chem. Biol. 2: 163-169.
51. Hasegawa, M., Smith, M.J., Iijima, M., Tabira, T., and Goedert, M. 1999. FTDP-17 mutations N279K and S305N in t produce increased splicing of exon 10. FEBS Lett. 443: 93-96.
52. Heise, H., Hoyer, W., Becker, S., Andronesi, O.C., Riedel, D., and Baldus, M. 2005. Molecular-level secondary structure, polymorphism, and dynamics of full-length α-synuclein fibrils studied by solid-state NMR. Proc. Natl. Acad. Sci. 102: 15871-15876.
53. Hong, M., Zhukareva, V., Vogelsberg-Ragaglia, V., Wszolek, Z., Reed, L., Miller, B.I., Geschwind, D.H., Bird, T.D., McKeel, D., Goate, A., et al. 1998. Mutation-specific functional impairments in distinct τ isoforms of hereditary FTDP-17. Science 282: 1914-1917.
54. Hutton, M., Lendon, C.L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. 1998. Association of missense and 5′-splice-site mutations in τ with the inherited dementia FTDP-17. Nature 393: 702-705.
55. Ingelsson, M., Fukumoto, H., Newell, K.L., Growdon, J.H., Hedley-Whyte, E.T., Frosch, M.P., Albert, M.S., Hyman, B.T., and Irizarry, M.C. 2004. Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 62: 925-931.
56. Iseki, E., Matsumura, T., Marui, W., Hino, H., Odawara, T., Sugiyama, N., Suzuki, K., Sawada, H., Arai, T., and Kosaka, K. 2001. Familial frontotemporal dementia and parkinsonism with a novel N296H mutation in exon 10 of the τ gene and a widespread τ accumulation in the glial cells. Acta Neuropathol. (Berl.) 102: 285-292.
57. Iwai, A., Yoshimoto, M., Masliah, E., and Saitoh, T. 1995. Non-Aβ component of Alzheimer's disease amyloid (NAC) is amyloidogenic. Biochemistry 34: 10139-10145.
58. Jakes, R., Novak, M., Davison, M., and Wischik, C.M. 1991. Identification of 3- and 4-repeat τ isoforms within the PHF in Alzheimer's disease. EMBO J. 10: 2725-2729.
59. Jao, C.C., Der-Sarkissian, A., Chen, J., and Langen, R. 2004. Structure of membrane-bound α-synuclein studied by site-directed spin labeling. Proc. Natl. Acad. Sci. 101: 8331-8336.
60. Jarrett, J.T., Berger, E.P., and Lansbury Jr., P.T. 1993. The carboxy terminus of the β-amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 32: 4693-4697.
61. Joachim, C.L., Duffy, L.K., Morris, J.H., and Selkoe, D.J. 1988. Protein chemical and immunocytochemical studies of meningovascular β-amyloid protein in Alzheimer's disease and normal aging. Brain Res. 474: 100-111.
62. Kenney, J.M., Knight, D., Wise, M.J., and Vollrath, F. 2002. Amyloidogenic nature of spider silk. Eur. J. Biochem. 269: 4159-4163.
63. Kheterpal, I., Williams, A., Murphy, C., Bledsoe, B., and Wetzel, R. 2001. Structural features of the Aβ amyloid fibril elucidated by limited proteolysis. Biochemistry 40: 11757-11767.
64. Kumar, S. and Bansal, M. 1998. Geometrical and sequence characteristics of α-helices in globular proteins. Biophys. J. 75: 1935-1944.
65. Kyte, J. and Doolittle, R.F. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157: 105-132.
66. Lewy, F.H. 1912. Paralysis agitans. In Pathologische Anatomie. Handbuch der Neurologie. (ed. M. Lewandowsky), pp. 920-933. Springer-Verlag, Berlin.
67. Linding, R., Schymkowitz, J., Rousseau, F., Diella, F., and Serrano, L. 2004. A comparative study of the relationship between protein structure and β-aggregation in globular and intrinsically disordered proteins. J. Mol. Biol. 342: 345-353.
68. Lopez De La Paz, M., Goldie, K., Zurdo, J., Lacroix, E., Dobson, C.M., Hoenger, A., and Serrano, L. 2002. De novo designed peptide-based amyloid fibrils. Proc. Natl. Acad. Sci. 99: 16052-16057.
69. Lührs, T., Ritter, C., Adrian, M., Riek-Loher, D., Bohrmann, B., Döbeli, H., Schubert, D., and Riek, R. 2005. 3D structure of Alzheimer's amyloid-β(1-42) fibrils. Proc. Natl. Acad. Sci. 102: 17342-17347.
70. Makin, O.S., Atkins, E., Sikorski, P., Johansson, J., and Serpell, L.C. 2005. Molecular basis for amyloid fibril formation and stability. Proc. Natl. Acad. Sci. 102: 315-320.
71. Margittai, M. and Langen, R. 2004. Template-assisted filament growth by parallel stacking of τ. Proc. Natl. Acad. Sci. 101: 10278-10283.
72. Margittai, M. and Langen, R. 2006. Side chain-dependent stacking modulates τ filament structure. J. Biol. Chem. 281: 37820-37827.
73. McCarron, M.O., Nicoll, J.A., Stewart, J., Cole, G.M., Yang, F., Ironside, J.W., Mann, D.M., Love, S., and Graham, D.I. 2000. Amyloid β-protein length and cerebral amyloid angiopathy-related haemorrhage. Neuroreport 11: 937-940.
74. McParland, V.J., Kad, N.M., Kalverda, A.P., Brown, A., Kirwin-Jones, P., Hunter, M.G., Sunde, M., and Radford, S.E. 2000. Partially unfolded states of β(2)-microglobulin and amyloid formation in vitro. Biochemistry 39: 8735-8746.
75. Miake, H., Mizusawa, H., Iwatsubo, T., and Hasegawa, M. 2002. Biochemical characterization of the core structure of α-synuclein filaments. J. Biol. Chem. 277: 19213-19219.
76. Miyamoto, K., Kowalska, A., Hasegawa, M., Tabira, T., Takahashi, K., Araki, W., Akiguchi, I., and Ikemoto, A. 2001. Familial frontotemporal dementia and parkinsonism with a novel mutation at an intron 10+11-splice site in the τ gene. Ann. Neurol. 50: 117-120.
77. Murakami, K., Irie, K., Morimoto, A., Ohigashi, H., Shindo, M., Nagao, M., Shimizu, T., and Shirasawa, T. 2002. Synthesis, aggregation, neurotoxicity, and secondary structure of various Aβ 1-42 mutants of familial Alzheimer's disease at positions 21-23. Biochem. Biophys. Res. Commun. 294: 5-10.
78. Nelson, R., Sawaya, M.R., Balbirnie, M., Madsen, A.O., Riekel, C., Grothe, R., and Eisenberg, D. 2005. Structure of the cross-β spine of amyloid-like fibrils. Nature 435: 773-778.
79. Novak, M., Kabat, J., and Wischik, C.M. 1993. Molecular characterization of the minimal protease resistant t unit of the Alzheimer's disease paired helical filament. EMBO J. 12: 365-370.
80. Pawar, A.P., Dubay, K.F., Zurdo, J., Chiti, F., Vendruscolo, M., and Dobson, C.M. 2005. Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. J. Mol. Biol. 350: 379-392.
81. Perutz, M.F. 1997. Amyloid fibrils. Mutations make enzyme polymerize. Nature 385: 773-775.
82. Petkova, A.T., Ishii, Y., Balbach, J.J., Antzutkin, O.N., Leapman, R.D., Delaglio, F., and Tycko, R. 2002. A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. 99: 16742-16747.
83. Petkova, A.T., Leapman, R.D., Guo, Z., Yau, W.M., Mattson, M.P., and Tycko, R. 2005. Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science 307: 262-265.
84. Prelli, F., Castano, E., Glenner, G.G., and Frangione, B. 1988. Differences between vascular and plaque core amyloid in Alzheimer's disease. J. Neurochem. 51: 648-651.
85. Reches, M., Porat, Y., and Gazit, E. 2002. Amyloid fibril formation by pentapeptide and tetrapeptide fragments of human calcitonin. J. Biol. Chem. 277: 35475-35480.
86. Roher, A.E., Lowenson, J.D., Clarke, S., Woods, A.S., Cotter, R.J., Gowing, E., and Ball, M.J. 1993. β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: Implications for the pathology of Alzheimer disease. Proc. Natl. Acad. Sci. 90: 10836-10840.
87. Sánchez de Groot, N., Pallarés, I., Avilés, F.X., Vendrell, J., and Ventura, S. 2005. Prediction of "hot spots" of aggregation in disease-linked polypeptides. BMC Struct. Biol. 5: 18.
88. Schiffer, M. and Edmundson, A.B. 1967. Use of helical wheels to represent the structures of proteins and to identify segments with helical potential. Biophys. J. 7: 121-135.
89. Segrest, J.P., Jones, M.K., De Loof, H., Brouillette, C.G., Venkatachalapathi, Y.V., and Anantharamaiah, G.M. 1992. The amphipathic helix in the exchangeable apolipoproteins: A review of secondary structure and function. J. Lipid Res. 33: 141-166.
90. Serpell, L.C., Berriman, J., Jakes, R., Goedert, M., and Crowther, R.A. 2000. Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation. Proc. Natl. Acad. Sci. 97: 4897-4902.
91. Siepen, J.A. and Westhead, D.R. 2002. The fibril_one on-line database: Mutations, experimental conditions, and trends associated with amyloid fibril formation. Protein Sci. 11: 1862-1866.
92. Spillantini, M.G., Schmidt, M.L., Lee, V.M.-Y., Trojanowski, J.Q., Jakes, R., and Goedert, M. 1997. α-Synuclein in Lewy bodies. Nature 388: 839-840.
93. Spillantini, M.G., Crowther, R.A., Jakes, R., Hasegawa, M., and Goedert, M. 1998a. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. 95: 6469-6473.
94. Spillantini, M.G., Murrell, J.R., Goedert, M., Farlow, M.R., Klug, A., and Ghetti, B. 1998b. Mutation in the τ gene in familial multiple system τ-opathy with presenile dementia. Proc. Natl. Acad. Sci. 95: 7737-7741.
95. Spillantini, M.G., Yoshida, H., Rizzini, C., Lantos, P.L., Khan, N., Rossor, M.N., Goedert, M., and Brown, J. 2000. A novel τ mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies. Ann. Neurol. 48: 939-943.
96. Sung, Y.H. and Eliezer, D. 2006. Secondary structure and dynamics of micelle bound β- and γ-synuclein. Protein Sci. 15: 1162-1174.
97. Suzuki, N., Iwatsubo, T., Odaka, A., Ishibashi, Y., Kitada, C., and Ihara, Y. 1994. High tissue content of soluble β1-40 is linked to cerebral amyloid angiopathy. Am. J. Pathol. 145: 452-460.
98. Tartaglia, G.G., Cavalli, A., Pellarin, R., and Caflisch, A. 2005. Prediction of aggregation rate and aggregation-prone segments in polypeptide sequences. Protein Sci. 14: 2723-2734.
99. Thompson, M.J., Sievers, S.A., Karanicolas, J., Ivanova, M.I., Baker, D., and Eisenberg, D. 2006. The 3D profile method for identifying fibril-forming segments of proteins. Proc. Natl. Acad. Sci. 103: 4074-4078.
100. Tjernberg, L., Hosia, W., Bark, N., Thyberg, J., and Johansson, J. 2002. Charge attraction and β propensity are necessary for amyloid fibril formation from tetrapeptides. J. Biol. Chem. 277: 43243-43246.
101. Torok, M., Milton, S., Kayed, R., Wu, P., McIntire, T., Glabe, C.G., and Langen, R. 2002. Structural and dynamic features of Alzheimer's Aβ peptide in amyloid fibrils studied by site-directed spin labeling. J. Biol. Chem. 277: 40810-40815.
102. Ulmer, T.S., Bax, A., Cole, N.B., and Nussbaum, R.L. 2005. Structure and dynamics of micelle-bound human α-synuclein. J. Biol. Chem. 280: 9595-9603.
103. van Swieten, J.C., Bronner, I.F., Azmani, A., Severijnen, L.A., Kamphorst, W., Ravid, R., Rizzu, P., Willemsen, R., and Heutink, P. 2007. The DeltaK280 mutation in MAP τ favors exon 10 skipping in vivo. J. Neuropathol. Exp. Neurol. 66: 17-25.
104. von Bergen, M., Barghorn, S., Li, L., Marx, A., Biernat, J., Mandelkow, E.M., and Mandelkow, E. 2001. Mutations of τ protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local β-structure. J. Biol. Chem. 276: 48165-48174.
105. Watson, A.A., Fairlie, D.P., and Craik, D.J. 1998. Solution structure of methionine-oxidized amyloid β-peptide (1-40). Does oxidation affect conformational switching? Biochemistry 37: 12700-12706.
106. 1-40 amyloid fibril secondary structure using nuclear magnetic resonance spectroscopy. Biochemistry 44: 4434-4441.
107. Williams, R.W., Chang, A., Juretic, D., and Loughran, S. 1987. Secondary structure predictions and medium range interactions. Biochim. Biophys. Acta 916: 200-204.
108. Williams, A.D., Portelius, E., Kheterpal, I., Guo, J.T., Cook, K.D., Xu, Y., and Wetzel, R. 2004. Mapping Aβ amyloid fibril secondary structure using scanning proline mutagenesis. J. Mol. Biol. 335: 833-842.
109. Wischik, C.M., Novak, M., Thogersen, H.C., Edwards, P.C., Runswick, M.J., Jakes, R., Walker, J.E., Milstein, C., Roth, M., and Klug, A. 1988. Isolation of a fragment of τ derived from the core of the paired helical filament of Alzheimer disease. Proc. Natl. Acad. Sci. 85: 4506-4510.
110. Yoshida, H., Crowther, R.A., and Goedert, M. 2002. Functional effects of τ gene mutations ΔN296 and N296H. J. Neurochem. 80: 548-551.
111. Yoshida, H., Craxton, M., Jakes, R., Zibaee, S., Tavare, R., Fraser, G., Serpell, L.C., Davletov, B., Crowther, R.A., and Goedert, M. 2006. Synuclein proteins of the pufferfish Fugu rubripes: Sequences and functional characterization. Biochemistry 45: 2599-2607.
112. Younkin, S.G. 1995. Evidence that Aβ 42 is the real culprit in Alzheimer's disease. Ann. Neurol. 37: 287-288.
113. Zurdo, J., Guijarro, J.I., Jiménez, J.L., Saibil, H.R., and Dobson, C.M. 2001. Dependence on solution conditions of aggregation and amyloid formation by an SH3 domain. J. Mol. Biol. 311: 325-340.